reference

DAFTAR PUSTAKA Al-Saif SM, Al-Habib KF, Ullah A, Hersi, AlFaleh H, Alnemer K et al. Age and

its relationship to acute coronary syndromes in the Saudi Project for Assessment of Coronary Events (SPACE) registry: The SPACE age study. J Saudi Heart Assoc.2011;8:1-8.

Alexander KP et al. Acute coronary care in the elderly, part I:

non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115(19):254969.

Antithrombotic Trialists Collaboration. Collaborative meta-analysis of

randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ.2002;324(7329):71-86.

Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al.

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2008;51;210-247

Antman EM, Cohen M, Bernink J. L, McCabe CH, Horacek, Papuchis G et al.The

TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000; 284: 835-42.

Antman EM . In Braunwalds Heart Disease A Text Book of Cardiovascular

Medicine ST-Segment Elevation Myocardial Infarction: Pathology, Pathophysiology, and Clinical Features. 9th

edition,2005: p.1098-1105.

Antoni ML, Bertini M, Atary JZ, Delgado V, Ellen AB, Boersma E et al. Predictive Value of Total Atrial Conduction Time Estimated with Tissue Doppler Imaging for the Development of New-Onset Atrial Fibrillation after Acute Myocardial Infarction. Am J Cardiol.2010;106: 198-203.

Arnon BM, Julia S and Yonathan H. Leukocytes and acute myocardial infarction.

IMAJ 2002;4:1060-5. Bilal A, Sindhu GA, Qureshi FS, Iqbal J. Predictive Value of Blood Glucose as an

Independent Risk factor for Progression/ Mortality in Acute Coronary Syndrome. A.P.M.C.2007;1:19-25.

Universitas Sumatera Utara

Braunwald E. Unstable angina: A classification. Circulation.1989;80:410-4. Boersma E, Maas AC, Deckers JW, Simons ML. Early thrombolytic treatment in

acute myocardial infarction reappraisal of the golden hour. Lancet.1996;348:771-5

Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon

time in acute myocardial infarction. N Engl J Med.2006;355:2308 20. Brodie BR, Stone GW, Morice MC, Cox DA, Garcia E, Mattos LA, et al.

Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol.2001;88:1085-90.

Budaj A, David B, Gabriel S, Shaun GG, Omar HD,Keith AA, et al. Global

patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: Insights from the Global Registry of Acute Coronary Events (GRACE).Am Heart J. 2003;146:999-1006.

Carlo DM. Treatment of acute myocardial infarction in Europe: Review of current

models and proposal of optimal common standards ESC STEMI Guidelines 2011. Diunduh dari : www.escardio.org/EAPCI.

Chen ZM, Pan HC, Chen YP , Peto R, Collins R, Jiang LX, et al. Early

intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Lancet.2005;366:1622-32.

Christenson RH, Duh SH, Newby LK, Ohman EM, Califf RM, Granger CB, et al.

Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem.1998;44:494-501.

Christopher PC, Braunwald E . In Braunwalds Heart Disease A Text Book of

Cardiovascular Medicine : Unstable Angina and NonST Elevation Myocardial Infarction. 9th

edition, 2005:p.1189-1220.

Cole DR, Singian EB, Kate LN. The long-term prognosis following myocardial infarction, and some factors which affect it. Circulation. 1954;9:321-34

David OW. Treatment delayed is treatment denied. Circulation.

2004;109:1806-09.


De Luca G, Suryapranata H, Ottervanger JP, et al. Time delay to treatment and

mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:122325.

Deckelbaum L.Chapter 11: Heart attacks and coronary artery disease. p.133-146.

Di unduh dari: http://www.pdfpedia.com/download/6925/heart-attacks-and-coronary-artery-disease-pdf.html.

Eagle KA, Fox KA, Gore JM, Steg PG, Anderson FA, GRACE and GRACE-2

Investigators. The Global Registry of Acute Coronary Events,1999 to 2009 GRACE. Heart. 2010;96:1095-101

Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S.

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet. 2000;355:1936-42.

Findlay IN, Cunningham AD. Definition of acute coronary syndrome. Heart.

2005;91(7):857-9. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for

fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.

Foo RSY, De Bono DP. Concepts in Acute Coronary Syndromes. Singapore Med J.

2000;41(12):606-610. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and

risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation.2004;110(10):1202-8.

Francisco JG, Juan RG, Manuel V, Luis M, Eugenia S,Francisca T et al. Use of a

Coronary Risk Score (the TIMI Risk Score) in a Non-Selected Patient Population Assessed for Chest Pain at an Emergency Department. Rev Esp Cardiol.2005;58:775-81.

Go AS, Barron HV, Rundle AC, Ornato JP, Avins AL. Bundle-branch block and

in-hospital mortality in acute myocardial infarction. National Registry of


Myocardial Infarction 2 Investigators. Ann Intern Med . 1998;129(9):690-7.

Hamm WC, Heeschen C, Falk E, Fox KAA. Acute coronary syndrome :

Pathophysiology, Diagnosis and risk stratification. Elsevier. 2004:p.333-367.

Huon GH, Keith DD, John MM, Iain AS. Lecture notes cardiology, Edisi

4.Erlangga Medical Series, Jakarta;2002:107-50. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: a simple risk score for

clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation.1999;100:599-607.

Katz R & Henry P. In Clinical Practice Series : Acute Coronary Syndromes. 1st

edition. Elsevier,2006: p.10-45

Kaul P, Newby LK, Yuling Fu, Hasselblad V, Mahaffey KW, Christenson RH et al. Troponin T and quantitative ST-Segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol. 2003;41:371 80.

Koon-Hou M, Topol EJ. Emerging concepts in the management of acute

myocardial infarction in patients with diabetes mellitus.J Am Coll Cardiol.2000;35:5638.

Krumholz HM, Chen J, Wang Y, et al. Comparing AMI mortality among hospitals

in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation. 1999;99:298692.

Lakhani MS, Qadir F, Hanif B, Farooq S, Khan M. Correlation of Thrombolysis in

Myocardial Infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome. JPMA.2010;60:197-201.

Levine GN, Eric RB, James CB, Steven RB, John A, Bojan C et al. 2011

ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:1-82.

Libby P. Molecular basis of the acute coronary syndromes. Circulation.


1995;91:2844-2850. Luepker RV, Apple FS, Christenson RH et al. Case Definitions for Acute

Coronary Heart Disease in Epidemiology and Clinical Research Studies. Circulation. 2003;108:2543-49.

Luciano B, Jaffe AS. Troponin: the biomarker of choice for the detection of

cardiac injury. CMAJ .2005;173:1191-202. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al.

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol.1995;26(1):57-65

Manoharan G, Ntalianis A, Muller O, Hamilos M,Sarno G, Melikian N. Severity

of coronary arterial stenoses responsible for acute coronary syndromes. J Am Coll Cardiol.2009;103:11838.

Marc SS, Elliott MA.The Thrombolysis In Myocardial Infarction Risk Score in

Unstable Angina/NonST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol.2003;41:89-95.

Milaveta JJ, Geibel DW, Christian TF, et al. Time to therapy and salvage in

myocardial infarction. J Am Coll Cardiol.1998;31:124651. Morrow AD, Antman EA, Parsons L , de Lemos J, Cannon CP, Giugliano RP,et al.

Application of the TIMI risk score for ST-Elevation MI in the National Registry of Myocardial Infarction 3. JAMA.2001;286:1356-9.

Morrow AD, Antman EM, Charlesworth A, et al.TIMI risk score for ST-elevation

myocardial infarction: a convenient, bedside, clinical score for risk assessmentat presentation: an InTIME II trial substudy.Circulation. 2000;102:2031-37.

Mueller C, Neumann FJ , Perruchoud AP, Buettner HJ. White blood cell count and

long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularization.Heart.2003;89:38992.

Munir TA, Afzal MN. Assessment of differential leukocyte count in patients with

acute coronary syndrome.JPMA.2010;60:548-52. Newby LK, Goldmann UB, Ohman EU.Troponin: An Important Prognostic

Marker and Risk-Stratification Tool in NonST-Segment Elevation Acute


Coronary Syndromes. J Am Coll Cardiology. 2003;41:31S36S. Nunez J, Lorenzo F, ngel L, Juan S, Vicent B, Vicente B et al. Prognostic value

of white blood cell count in acute myocardial infarction: Long-Term mortality. Rev Esp Cardiol. 2005;58:631-9.

Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for

risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med.1996;335:1333-41.

Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia. Pedoman Tatalaksana

Penyakit Kardiovaskuler di Indonesia. Edisi ke-3;2012:3-54. Pollack CV Jr., Sites FD, Shofer FS, Sease KL, Hollander JE et al. Application of

the TIMI Risk Score for Unstable Angina and Non-ST Elevation Acute Coronary Syndrome to an Unselected Emergency Department Chest Pain Population. Academic Emergency Medicine. 2006;13:1318.

Palwasha S, Khan AA, Sahibzada WA. The Impact of Hyperglycaemia on

Morbidity and mortality of Acute Coronary Syndromes and Acute Myocardial Infarction. J Ayub Med Coll Abbottabad Pakistan. 2009; 21:110-5

Rathore SS, Weinfurt KP, Foody JM and Krumholz HM. Performance of the

thrombolysis in myocardial infarction (TIMI) ST-elevation myocardial infarction risk score in a national cohort of elderly patients. Am Heart J. 2005;150:40210.

Rationale and design of the GRACE (Global Registry of Acute Coronary Events)

Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J .2001;141(2):190-9.

Roxana M, Stuart JP, Gregg WS, Tim CC, George DD, Frederick F et al.

Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. European Heart Journal.2009;30:145766.

Saman R, Jan PO, Jan-Henk E D, Menko BJ, Jan CA, Marcel G et al. Are patients

with non-ST elevation myocardial infarction undertreated? BMC Cardiovascular Disorders.2007;7:1-8.

Sabatine MS, Cannon CP, Gibson CM, Lpez-Sendn JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for


myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-89

Sacks FM, Pfeffer MA, Moye LA.The effect of pravastatin on coronary events

after myocardial infarction in patients with average choleterol levels. N Engl J Med.1996;3:1001-9.

Scirica BM, et al. Unstable Angina/Non-segmen ST-Elevasi Myocard Infark .

Data from TIMI III Registr. J Am Coll Cardiol.2002:29-41. Scottish Intercollegiate Guidelines Network (SIGN). Acute coronary syndromes :

A national clinical guideline.1st published.2007:p.1-59. Diunduh dari : www.sign.ac.uk.

Sean MS, Garrick CS, Carolyn HM, Satishkumar M, Sabina AM, Christopher PC.

Diabetes and Mortality Following Acute Coronary Syndromes. JAMA.2007;298:765-75.

Sohby M, Antepara N, Escobar, Alam, Leizorovicz A, Martinez C. Management

of acute coronary syndromes in developing countries: The ACCESS registry. Diunduh dari http://www.escardio.org/congresses/esc-2010/congress-reports/ Documents/Monday/ACCESS-presenter-slides-Sobhy.pdf

Soiza RL, Leslie SJ, Williamson P,Wai S, Harrild K, Peden NR and Hargreaves

AD.Risk stratification in acute coronary syndromesdoes the TIMI risk score work in unselected cases? Q J Med.2006;99:817.

Theroux P, Welsh RC. Meta-analysis of randomized trials comparing enoxaparin

versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction. Am J Cardiol. 2003; 91(7):860-4.

Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM and

Pajak.A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in38 populations from 21 countries in four continents. Circulation.1994;90:583-612.

van der Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al.

Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24(1):28-66.


Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1

year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000;356(9223):9-16.

Wright RS, Cynthia DA, Jeffrey LA, Theodore GG, Donald EC, Jr, Steven ME et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non_ST-Elevation Myocardial Infarction (Updating the 2007 Guideline. J. Am. Coll. Cardiol. 2011;57;1920-1959.

Wong GC, Giugliano RP, Antman EM. Use of low-molecular-weight heparins in

the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA.2003;289(3):331-42.

Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ , Blumenthal M, et al.

Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003;107:966-72.

Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in

heart disease. II. Unstable angina, heart failure,primary prevention with aspirin, and risk factor modification. JAMA.1988;260:2259-63.

Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L. Clinical

characteristics and outcome of patients with early (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. European Heart Journal.2002;23:5507
